Biosyntia is an industrial biotech company developing novel fermentation processes to commercially cost-effectively produce fine chemicals. They have a unique capability to develop cost effective processes within a defined group of molecules. Their strong focus on a select group of molecules has made them the leading expert on optimizing organisms for producing these molecules. For our target ingredients, they have also developed a unique selection technology to replace conventional screening. This dramatically reduces R&D cost and time to develop high-yielding strains and hence lower cost of R&D development as well as final commercial production. Their target molecules go into markets such as flavor, food and feed. Examples are selected 8-vitamins and nutraceuticals. Their capabilities are both within strain and process optimization.